Clinical trials sponsored by First People's Hospital of Hangzhou
3
Recruiting trials
6
Conditions studied
Phase breakdown
Phase 2 1Phase 4 1Not applicable 1
Conditions studied
| Condition | Trials |
|---|---|
| Lung cancer | 2 |
| Chronic Hepatitis b | 1 |
| Hepatitis B | 1 |
| Non-Small Cell Lung Cancer | 1 |
| Signet Ring Cell Carcinoma of the Lung | 1 |
| Tenofovir Alafenamide Fumarate | 1 |
Recruiting trials led by First People's Hospital of Hangzhou
- Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC
- Multi Omics Molecular Characteristics and Immunophenotyping of Lung Signet Ring Cell Carcinoma
- Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women
Common questions
How many trials is First People's Hospital of Hangzhou recruiting for?
First People's Hospital of Hangzhou is the lead sponsor of 3 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.